V

Velocity Clinical Research | Savannah, GA

Research site

(Unclaimed)

Location

340 Eisenhower Drive Suite 1500, Savannah, Georgia, United States of America

Site insights

Top conditions

Top treatments

Tolebrutinib

SAR442168

PERSEUS

QCZ484

JATENZO®

Tyrosine

Parent organization

This site is a part of Velocity Clinical Research

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 11 total trials

A Phase 4 Study to Evaluate Adrenal Function in Hypogonadal Men Treated With JATENZO® for 12 Months

TOL-CLAR-20024 is a Phase 4, multi-center, open-label safety study evaluating the potential effect of JATENZO on adrenal function in hypogonadal men...

Active, not recruiting

Hypogonadism

Drug: Jatenzo

A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1195, in 18- to 55-Year-Old Healthy Participants

The purpose of this study is to evaluate the safety and reactogenicity of mRNA-1195 in healthy participants.

Active, not recruiting

Epstein-Barr Virus Infection

Biological: Placebo

Biological: mRNA-1195.1

A Study to Identify an Optimal Dose of QCZ484 in Mild to Moderate Hypertensive Patients

The purpose of this study is to evaluate the efficacy, safety and tolerability of QCZ484 or placebo, given subcutaneously, every 6 months, at differe...

Enrolling

Hypertension

Drug: QCZ484

Other: Saline

A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.

This is a Phase 3 extension, global, multicenter study to assess the long-term safety and tolerability of tolebrutinib in adult participants (aged ≥1...

Active, not recruiting

Secondary Progressive Multiple Sclerosis

Relapsing Multiple Sclerosis

Drug: Teriflunomide

Drug: Placebo

Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS (ALITHIOS)

The purpose of this study is to collect long-term safety, tolerability, effectiveness and health outcomes data in eligible subjects who have particip...

Active, not recruiting

Relapsing Multiple Sclerosis

Biological: 23-valent pneumococcal polysaccharide vaccine (23-PPV)

Biological: Tetanus toxoid (TT) containing vaccine (Td, Tdap)